Clinical laboratories have again avoided a potential financial disaster, at least for now, after Congress shifted PAMA cuts to test reimbursement rates until January 2027. However, the victory is temporary absent permanent PAMA reform. To that end, laboratory leaders need to push lawmakers to pass the RESULTS Act, with one healthcare attorney suggesting that labs […]
PAMA Cuts Averted Until 2027; Labs Must Plan Next Move
Also in the February 9, 2026 issue, patient-driven testing is spurring new opportunities
- By Robert Michel
- > From the Volume XXXIII, No. 2 - February 9, 2026 Issue
